— Know what they know.
Not Investment Advice
Also trades as: PRM.L (LSE) · $vol 0M

PMSNF OTC

Proteome Sciences plc
1W: +0.0% 1M: +0.0% 3M: -50.0% YTD: -75.0% 1Y: -80.0% 3Y: -99.1%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Specialties · Tech Score Strong Sell · Power 38 · $2.9M mcap · 222M float · 0.0005% daily turnover · Short 88% of daily vol

Balance Sheet Trends

Total Assets
$9M -19.6% ▼
5Y CAGR: +1.9%
Total Liabilities
$16M +8.3% ▲
5Y CAGR: +5.5%
Shareholders Equity
-$7M -112.5% ▼
Cash & Investments
$1M -44.4% ▼
5Y CAGR: +7.1%
Total Debt
$15M +7.8% ▲
5Y CAGR: +6.0%
Net Debt
$13M +17.0% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$2M$4M$2M$1M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$2M$2M$4M$2M$1M
Net Receivables$1M$927K$2M$1M$509K
Inventory$878K$1M$901K$837K$732K
Other Current Assets$63K$53K$172K$78K$84K
Total Current Assets$4M$5M$7M$4M$3M
Property, Plant & Equip.$542K$1M$1M$3M$2M
Goodwill & Intangibles$4M$4M$4M$4M$4M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$5M$5M$6M$7M$7M
Total Assets$9M$10M$12M$11M$9M
— Liabilities —
Accounts Payable$519K$375K$672K$449K$639K
Short-Term Debt$11M$11M$11M$11M$13M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$153K$35K$104K$1K-$1K
Total Current Liabilities$12M$12M$12M$12M$14M
Long-Term Debt$0$0$0$0$250K
Other Non-Current Liab.$492K$499K$434K$419K$422K
Total Non-Current Liabilities$851K$1M$787K$2M$2M
Total Liabilities$12M$13M$13M$15M$16M
— Equity —
Common Stock$3M$3M$3M$3M$3M
Retained Earnings-$72M-$72M-$71M-$73M-$76M
Accumulated OCI$14M$15M$15M$15M$15M
Total Stockholders Equity-$3M-$3M-$843K-$3M-$7M
Total Liabilities & Equity$9M$10M$12M$11M$9M
— Key Metrics —
Total Debt$11M$12M$12M$13M$15M
Net Debt$9M$9M$8M$11M$13M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms